BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18524195)

  • 21. Results of probing for congenital nasolacrimal duct obstruction in children older than 13 months of age.
    Maheshwari R
    Indian J Ophthalmol; 2005 Mar; 53(1):49-51. PubMed ID: 15829747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of nasolacrimal duct obstruction in children between 18 months and 4 years old.
    Kushner BJ
    J AAPOS; 1998 Feb; 2(1):57-60. PubMed ID: 10532369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balloon catheter dilation for complex congenital nasolacrimal duct obstruction in older children.
    Maheshwari R
    J Pediatr Ophthalmol Strabismus; 2009; 46(4):215-7. PubMed ID: 19645399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of nasolacrimal duct probing in children between 9-48 months.
    Medghalchi A; Mohammadi MJ; Soltani Moghadam R; Dalili H
    Acta Med Iran; 2014; 52(7):545-51. PubMed ID: 25135264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late probing for congenital nasolacrimal duct obstruction.
    Maheshwari R; Maheshawri S
    J Coll Physicians Surg Pak; 2007 Jan; 17(1):41-3. PubMed ID: 17204219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Success of probing for congenital nasolacrimal duct obstruction in children under 10 years of age.
    Thongthong K; Singha P; Liabsuetrakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1646-50. PubMed ID: 20043568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?
    Kashkouli MB; Beigi B; Parvaresh MM; Kassaee A; Tabatabaee Z
    Br J Ophthalmol; 2003 Sep; 87(9):1151-3. PubMed ID: 12928286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balloon catheter dilation as the primary treatment of congenital nasolacrimal duct obstruction.
    Gazit I; Pras E; Or L; Hartstein ME
    Eur J Ophthalmol; 2021 Mar; 31(2):334-339. PubMed ID: 31888382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Success rate of late primary probing in congenital nasolacrimal duct obstruction.
    Rajabi MT; Abrishami Y; Hosseini SS; Tabatabaee SZ; Rajabi MB; Hurwitz JJ
    J Pediatr Ophthalmol Strabismus; 2014; 51(6):360-2. PubMed ID: 25215516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Success rates of endoscopic-assisted probing for congenital nasolacrimal duct obstruction in children.
    Theodoropoulou S; Sutherland MS; Haddow K; Blaikie A
    J Laryngol Otol; 2013 Aug; 127(8):794-8. PubMed ID: 23803229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing.
    Goldstein SM; Goldstein JB; Katowitz JA
    Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):352-7. PubMed ID: 15377901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative prognostic factors for probing outcome in children with congenital nasolacrimal duct obstruction.
    Andalib D; Nabei R
    Eur J Ophthalmol; 2013; 23(3):329-32. PubMed ID: 23225091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.
    Gunton KB; Chung CW; Schnall BM; Prieto D; Wexler A; Koller HP
    J AAPOS; 2001 Jun; 5(3):139-42. PubMed ID: 11404738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasolacrimal duct obstruction in children: outcome of intubation.
    Lim CS; Martin F; Beckenham T; Cumming RG
    J AAPOS; 2004 Oct; 8(5):466-72. PubMed ID: 15492741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balloon dilation of the nasolacrimal duct.
    Tien DR; Young D
    J AAPOS; 2005 Oct; 9(5):465-7. PubMed ID: 16213397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.